Peregrine Capital Management’s OptiNose OPTN Stock Holding History

Peregrine Capital Management’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-21,163	Closed	-$6.36M	–	311
2018 Q1	$6.36M	Sell	21,163 -1,108	-5%	-$307K	0.16%	221
2017 Q4	$6.31M	Buy	+22,271	New	+$6.27M	0.15%	232

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Peregrine Capital Management's OPTN Position: Q2 2018 in Review

Peregrine Capital Management sold out of OptiNose (OPTN) in Q2 2018, closing a stake of 21,163 shares — an estimated $6.36M sold.

Peregrine Capital Management first reported a position in OPTN in Q4 2017 and held it in 2 quarters. The position peaked at $6.36M in Q1 2018. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2018.

Peregrine Capital Management reported no remaining OptiNose position as of Q2 2018 after selling out during the quarter.
Peregrine Capital Management sold 21,163 OptiNose shares in Q2 2018, an estimated $6.36M.
Peregrine Capital Management first reported a position in OptiNose in Q4 2017 and held it in 2 quarters.
Peregrine Capital Management's OptiNose position peaked at $6.36M in Q1 2018.
72 funds tracked by Wall St. Rank held OptiNose as of Q2 2018.

Based on Peregrine Capital Management's 13F filing for Q2 2018, filed 12 Jul 2018.